Eveline Wu
Allergy · Chapel Hill, NCNPI 1770630584
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Pharming Healthcare, Inc. accounts for 92.8% of it on its own, with 8 other manufacturers making up the rest.
Across 154 payments — averaging $884.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$126K
- Sumitomo Pharma America, Inc.$8K
- Astrazeneca UK Limited$2K
- AstraZeneca$131
- AbbVie$125
- Sobi, Inc$123
- plus $167 from 3 others
Across 30 payments — averaging $31,408 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$423K
- Amgen$303K
- Sumitomo Pharma America, Inc.$69K
- Janssen Research & Development, LLC$46K
- Pfizer$38K
- AbbVie$31K
- plus $33K from 3 others
What the payments were for
- Consulting fees$78,25057%
- Speaking & faculty fees$39,70529%
- Travel & lodging$16,27012%
- Food & beverage$1,9361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 126 | $126,308 |
| Sumitomo Pharma America, Inc. | 9 | $7,796 |
| Astrazeneca UK Limited | 13 | $1,512 |
| AstraZeneca | 1 | $131 |
| AbbVie | 1 | $125 |
| Sobi, Inc | 1 | $123 |
| ADMA Biomanufacturing LLC | 1 | $111 |
| Genentech USA, Inc. | 1 | $36 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few allergy providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JoenjaLeniolisib Phosphate | 11 | $529,808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Pharming Healthcare, Inc.Joenja | $126,308 | $529,80811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in North Carolinaon file to place this against a meaningful peer group, so we don't.
Other allergy in Chapel Hill
- Hunter SmithChapel Hill$242
- Mildred KwanChapel Hill$11
- Yoon KimGreensboro$14K
- Robert van WinkleGreensboro$5K
- Charles HumphriesCharlotte$4K
- Meg WhelanGreensboro$4K
- Ranjan SharmaGreensboro$2K
- Thomas OfferleCharlotte$781
- Katherine OberhelmanGreensboro$365
- Elizabeth IsbisterHarbinger$15
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.